Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 13, 2022 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Plan to Commercialize a Diagnostic Test for Early Lyme Disease

LEXINGTON, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
October 12, 2022 08:35 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook

LEXINGTON, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
October 12, 2022 08:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Reverse Stock Split Effective Today

LEXINGTON, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
September 29, 2022 08:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million

LEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
September 22, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Commercial Expansion Through Distributor in Baltic Region

LEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced...
September 08, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Participate in the H.C. Wainwright Global Investment Conference

LEXINGTON, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
August 18, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

LEXINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
August 15, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Second Quarter 2022 Financial Results

LEXINGTON, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
August 09, 2022 08:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox Virus

LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
July 29, 2022 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., July 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards...